Quest Laboratories (NSE:QUESTLAB) Other Long-Term Liabilities: ₹9.0 Mil (As of Mar. 2026)


NSE:QUESTLAB Quest Laboratories Ltd NSE:QUESTLAB
52 GF Score
Price ₹94.95
! 7 Warning Signs
View Full Analysis

What is Quest Laboratories Other Long-Term Liabilities?

Quest Laboratories NSE:QUESTLAB +1.28% 52 Other Long-Term Liabilities is ₹9.0 Mil as of Mar. 2026. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 52/100. The stock has 7 warning signs investors should review.

Quest Laboratories's other long-term liabilities for the quarter that ended in Mar. 2026 was ₹9.0 Mil.

Quest Laboratories's quarterly other long-term liabilities declined from Mar. 2025 (₹13.1 Mil) to Sep. 2025 (₹13.1 Mil) and declined from Sep. 2025 (₹13.1 Mil) to Mar. 2026 (₹9.0 Mil).

Quest Laboratories's annual other long-term liabilities increased from Mar. 2024 (₹7.6 Mil) to Mar. 2025 (₹13.1 Mil) but then declined from Mar. 2025 (₹13.1 Mil) to Mar. 2026 (₹9.0 Mil).

Quest Laboratories Other Long-Term Liabilities Related Terms

Quest Laboratories Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Quest Laboratories's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Laboratories Other Long-Term Liabilities Chart

Quest Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Long-Term Liabilities
Get a 7-Day Free Trial 4.59 6.23 7.63 13.11 9.02

Quest Laboratories Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.63 0.00 13.11 13.11 9.02
NSE:QUESTLAB
52GF Score
Quest Laboratories Ltd NSE:QUESTLAB
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quest Laboratories Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of ₹9.0 Mil mean?
Quest Laboratories (NSE:QUESTLAB) has a Other Long-Term Liabilities of ₹9.0 Mil as of Mar. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Quest Laboratories and its competitors.
Is Quest Laboratories' Other Long-Term Liabilities too high?
Quest Laboratories' current Other Long-Term Liabilities is ₹9.0 Mil. Overall, Quest Laboratories has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' Other Long-Term Liabilities compare to LLY and JNJ?
Quest Laboratories' Other Long-Term Liabilities of ₹9.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Drug Manufacturers company?
A good Other Long-Term Liabilities depends on the Drug Manufacturers industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Quest Laboratories and its competitors. Quest Laboratories's current Other Long-Term Liabilities is ₹9.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current Other Long-Term Liabilities of ₹9.0 Mil. The current Other Long-Term Liabilities is ₹9.0 Mil. Quest Laboratories' overall GF Score™ is 52/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current Other Long-Term Liabilities is ₹9.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest Laboratories Business Description

Address Sector III, Plot No. 45, Pithampur Industrial Area, Opposite Kissan Pipe Unit 4, District Dhar, Pithampur, Dhar, MP, IND, 454775
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
52GF Score

Get the complete analysis for NSE:QUESTLAB

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹94.95
Price